BIBLIOGRAPHIC RECORD

Ketamine based drug should be available for treatment resistant depression, says FDA panel

This record contains bibliographic metadata. Open the linked source to check the work; the record does not include its full text.

Recorded authors
Joanne Silberner
Source of metadata
OpenAlex
Year recorded
2019

Public identifiers and source

Open the source record

Reference

Joanne Silberner. (2019). Ketamine based drug should be available for treatment resistant depression, says FDA panel. https://openalex.org/W2915771341

Reference assembled from the available metadata. Check and cite the original publication before reusing a claim.

Permanent record URL: https://brain.psiconautica.org/en/documentos/d-9b9588e4ac230cdb1b9bf4ed46025492/